Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-461-7 | CAS number: -
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 31 July 2012 to 02 August 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed in accordance with OECD, EU, US EPA and JMAFF test guidelines in compliance with GLP and reported with a valid GLP certificate.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF), 12 Nohsan, Notification No. 8147, April 2011; including the most recent partial revisions.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The LLNA test method was not suitable for the test article.
Test material
- Reference substance name:
- branched and linear mono-C20,22,24 and di-C10-C13 alkyl benzenesulfonic acids and petroleum sulphonic acids, barium salts
- EC Number:
- 701-461-7
- Molecular formula:
- BaC32H50S2O6 to BaC104H186S2O6 General series and/or BaC66H98S4O6 to BaC84H142S4O6 Dibenzothiophene series
- IUPAC Name:
- branched and linear mono-C20,22,24 and di-C10-C13 alkyl benzenesulfonic acids and petroleum sulphonic acids, barium salts
- Reference substance name:
- Benzenesulfonic Acid, di C10-18-alkyl derivs barium salts, neutral, in diluents oil and TBN = <10
- IUPAC Name:
- Benzenesulfonic Acid, di C10-18-alkyl derivs barium salts, neutral, in diluents oil and TBN = <10
- Test material form:
- liquid: viscous
- Details on test material:
- Test substance information
Identification: 93820-55-4 Benzenesulfonic Acid, di C10-18-alkyl derivs barium salts, neutral, in diluents oil and TBN = <10
Molecular formula: UVCB
Molecular weight: UVCB
CAS Number: 93820-55-4
Description: Clear brown viscous liquid (determined at WIL Research Europe)
Batch: Not indicated
Purity/Composition: UVCB 100%
Test substance storage: At room temperature in the dark
Stability under storage conditions: Stable
Expiry date: 31 May 2013
Study specific test substance information
Hygroscopic: No
Volatile: No
Stability in vehicle:
Kaydol White Mineral Oil: Stable
Solubility in vehicle:
Kaydol White Mineral oil: Miscible
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- Test system
Species: Albino guinea pig, Dunkin Hartley strain, (SPF-quality). Recognized by international guidelines as the recommended test system (e.g. OECD, EC).
Source: Charles River Deutschland, Kisslegg, Germany.
Number of animals
Experimental group: 20 females.
Control group: 10 females.
(females were nulliparous and non-pregnant).
Age: Young adult animals (approx. 5 weeks old) were selected.
Identification: Ear tattoo.
Health inspection: A health inspection was performed prior to treatment, to ensure that the animals are in a good state of health. Special attention was paid to the skin to be treated, which was intact and free from any abnormality.
Animal husbandry
Conditions: Environmental controls for the animal room were set to maintain 18 to 24°C, a relative humidity of 40 to 70%, approximately 15 room air changes/hour, and a 12-hour light/12-hour dark cycle. Any variations to these conditions were maintained in the raw data and had no effect on the outcome of the study.
Accommodation: Group housing of maximally 5 animals per labeled Noryl cage (Tecniplast; 74 cm x 54 cm x 25 cm height) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France) and shelters (CS3B02A Play tunnels (90 mm x 5 mm x 125 mm), Datesand, Manchester, UK) as cage enrichment.
The acclimatization period was at least 5 days before the start of treatment under laboratory conditions.
Diet: Complete breeding diet for guinea pigs (SSNIFF® MS-Z, V2273; SSNIFF® Spezialdiäten GmbH, Soest, Germany). Hay (TecniLab-BMI BV, Someren, The Netherlands) was provided at least twice a week.
Water: Free access to tap water.
Results of analysis for diet, sawdust, shelters and water were assessed and did not reveal any findings that were considered to have affected the study integrity. All certificates and results of analysis are retained in the WIL Research Europe archives.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Kaydol White Mineral Oil
- Concentration / amount:
- Induction: 0.5 mL of the undiluted test substance concentration
Challenge: undiluted test substance and the vehicle (0.1 mL of each)
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Kaydol White Mineral Oil
- Concentration / amount:
- Induction: 0.5 mL of the undiluted test substance concentration
Challenge: undiluted test substance and the vehicle (0.1 mL of each)
- No. of animals per dose:
- Control: 10 animals
Experimental test group: 20 animals - Details on study design:
- Preliminary irritation study: A preliminary irritation study was conducted in order to select test substance concentrations to be used in the Main Study. The selection of concentrations was based on the following criteria:
- The concentrations are well-tolerated by the animals.
- For the induction exposures: the highest possible concentration that produced mild irritation (grade 2)
- For challenge exposure: the maximum non-irritant concentration.
A series of test substance concentrations was tested. Practical feasibility of administration determined the highest starting-concentration. The starting- and subsequent concentrations were taken from the series: 100% (undiluted), 50%, 20%, 10%, and, if needed, further lower concentrations using the same steps. The test system, procedures and techniques were identical to those used during the main study, unless otherwise specified. The animals selected were between 4 and 9 weeks old. No bodyweights were determined.
Epidermal application: A series of four test substance concentrations was used, the highest concentration being the maximum concentration that could technically be applied. Two different concentrations were applied (0.5 mL each) per animal to the clipped flank using Metalline patches (2x3 cm) mounted on Medical tape, which will be held in place with Micropore tape and subsequently Coban elastic bandage.
After 6 hours, the dressings were removed and the skin cleaned of residual test substance with Kaydol White Mineral Oil. The resulting dermal reactions were assessed for irritation 24 and 48 hours after exposure.
Main study
INDUCTION - Experimental animals
Days 1, 8 and 15: The left side of the scapular region was clipped and subsequently epidermally treated with 0.5 mL of the undiluted test substance concentration, using Metalline patches (2x3 cm) mounted on Medical tape, which was held in place with Micropore tape and subsequently Coban elastic bandage.
After 6 hours, the dressings were removed and the skin cleaned of residual test substance using Kaydol White Mineral Oil. Immediately after removal of the last induction application on Day 15, the treated skin area was assessed for irritation.
INDUCTION - Control animals
The control animals were treated as described for the experimental animals, except that, instead of the test substance, vehicle alone was administered.
CHALLENGE - All animals
Day 29: The right flank of all animals was clipped and subsequently treated epidermally with the undiluted test substance and the vehicle (0.1 mL of each), using Patch Test Plasters (Curatest®, Lohmann, Almere, The Netherlands). The patches were held in place with Micropore tape and subsequently Coban elastic bandage.
After 6 hours, the dressings were removed and the skin cleaned of residual test substance and vehicle using Kaydol White Mineral Oil. The treated sites were assessed for challenge reactions 24 and 48 hours after removal of the dressings.
After termination, animals were sacrificed using isoflurane and an intra-peritoneal injection of Euthasol® 20%.
Observations:
Mortality/Viability: Twice daily.
Toxicity: At least once daily.
Bodyweights: Prior to start and at termination of the study.
Necropsy: No necropsy was performed according to protocol.
Irritation: Skin reactions were graded according to the following numerical scoring systems.
Furthermore, a description of all other (local) effects was recorded. To facilitate scoring, the epidermally treated skin-areas were clipped at least 3 hours before the 48-hour reading of these areas in the preliminary irritation study and challenge phase. - Challenge controls:
- The control animals were treated as described for the experimental animals, except that, instead of the test substance, vehicle alone was administered.
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- Postive control not utilised in this study.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 7
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 7.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- Scaliness in 2/20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 3.0. Total no. in groups: 20.0. Clinical observations: Scaliness in 2/20 .
Any other information on results incl. tables
Table 1: PRELIMINARY IRRITATION STUDY
SKIN REACTIONS AFTER EPIDERMAL EXPOSURE
Animal number |
Conc. % |
24 hours after exposure |
48 hours after exposure |
||
Erythema |
Oedema |
Erythema |
Oedema |
||
(grade) |
(grade) |
(grade) |
(grade) |
||
5 |
100 |
0 |
0 |
0 |
0 |
50 |
0 |
0 |
0 |
0 |
|
6 |
100 |
0 |
0 |
0 |
0 |
50 |
0 |
0 |
0 |
0 |
|
7 |
20 |
0 |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
0 |
|
8 |
20 |
0 |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
0 |
|
Table 2: INDUCTION AND CHALLENGE READINGS
Animal No |
Induction |
Challenge |
||||
Day 15 |
Day 30 |
Day 31 |
||||
Readings |
24 Hour Readings |
48 Hour Readings |
||||
100% # |
100% |
Vehicle |
100% |
Vehicle |
||
Er |
Oe |
|
|
|
|
|
Control |
||||||
61 |
0 |
0 |
0 |
0 |
0 |
0 |
62 |
0 |
0 |
0 |
0 |
0 |
0 |
63 |
0p |
0 |
0 |
0 |
0 |
0 |
64 |
0 |
0 |
0 |
0 |
0 |
0 |
65 |
0p |
0 |
0 |
0 |
0 |
0 |
66 |
0 |
0 |
0 |
0 |
0 |
0 |
67 |
0 |
0 |
0 |
0 |
0 |
0 |
68 |
0 |
0 |
0 |
0 |
0 |
0 |
69 |
0 |
0 |
0 |
0 |
0 |
0 |
70 |
0 |
0 |
0 |
0 |
0 |
0 |
Experimental |
||||||
71 |
1 |
0 |
0 |
0 |
0 |
0 |
72 |
1p |
0 |
1 |
0 |
1 |
0 |
73 |
0 |
0 |
0 |
0 |
0 |
0 |
74 |
0 |
0 |
0 |
0 |
0 |
0 |
75 |
1 |
0 |
0 |
0 |
0 |
0 |
76 |
1 |
0 |
0 |
0 |
0 |
0 |
77 |
1 |
0 |
1 |
0 |
0 |
0 |
78 |
0 |
0 |
0 |
0 |
0 |
0 |
79 |
1 |
0 |
1 |
0 |
0 |
0 |
80 |
0 |
0 |
0 |
0 |
0 |
0 |
81 |
1 |
0 |
1 |
0 |
1p |
0 |
82 |
1 |
0 |
1 |
0 |
0 |
0 |
83 |
1 |
0 |
0 |
0 |
0 |
0 |
84 |
0 |
0 |
0 |
0 |
0 |
0 |
85 |
1 |
0 |
0 |
0 |
0 |
0 |
86 |
1p |
0 |
0 |
0 |
0 |
0 |
87 |
1p |
0 |
1 |
0 |
1 |
0 |
88 |
1 |
0 |
1 |
0 |
0p |
0 |
89 |
0p |
0 |
0 |
0 |
0 |
0 |
90 |
1 |
0 |
0 |
0 |
0 |
0 |
#. Test substance concentration (experimental animals) or vehicle (control animals).
Er: Erythema
Oe: Oedema
p. Scaliness
Vehicle: Kaydol White Mineral Oil.
Table 3: BODYWEIGHTS (GRAM)
SEX/DOSE LEVEL |
ANIMAL |
DAY 1 |
DAY 31 |
FEMALES CONTROL |
|||
|
61 |
320 |
518 |
|
62 |
303 |
439 |
|
63 |
322 |
502 |
|
64 |
348 |
515 |
|
65 |
332 |
513 |
|
66 |
326 |
495 |
|
67 |
315 |
475 |
|
68 |
310 |
486 |
|
69 |
301 |
425 |
|
70 |
307 |
443 |
|
MEAN |
318 |
481 |
|
ST.DEV. |
14 |
34 |
|
N |
10 |
10 |
FEMALES EXPERIMENTAL |
|||
|
71 |
325 |
491 |
|
72 |
316 |
471 |
|
73 |
341 |
518 |
|
74 |
324 |
519 |
|
75 |
310 |
416 |
|
76 |
324 |
448 |
|
77 |
327 |
497 |
|
78 |
341 |
495 |
|
79 |
295 |
491 |
|
80 |
311 |
422 |
|
81 |
320 |
447 |
|
82 |
311 |
473 |
|
83 |
306 |
437 |
|
84 |
314 |
446 |
|
85 |
340 |
495 |
|
86 |
294 |
448 |
|
87 |
303 |
471 |
|
88 |
345 |
524 |
|
89 |
325 |
468 |
|
90 |
355 |
539 |
|
MEAN |
321 |
476 |
|
ST.DEV. |
17 |
35 |
|
N |
20 |
20 |
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The skin reactions observed in response to the undiluted test substance in seven of the twenty, (35%) experimental animals in the challenge phase were considered indicative of sensitization, based on the ≥15% criteria for evidence of skin sensitisation and the absence of any response in the control animals.
- Executive summary:
Assessment of Contact Hypersensitivity to 93820-55-4 Benzenesulfonic Acid, di C10-18-alkyl derivs barium salts, neutral, in diluents oil and TBN = <10 in the Albino Guinea Pig (Buehler Test).
The study was carried out based on the guidelines and test method described in:
OECD No. 406 (1992), "Skin Sensitization"
EC No 440/2008; B6: "Skin Sensitization: Buehler Test”.
EPA OPPTS 870.2600 (2003) “Skin Sensitization”
JMAFF: Japanese Test Guidelines (2000) including the most recent partial revisions.
The Buehler type of sensitization test is selected at the request of the sponsor since this substance is a surfactant. Studies have shown that the preferred sensitization test (Local Lymph Node Assay) over predicts sensitization potential of these substances
Test substance concentrations selected for the Main study were based on the results of a preliminary study.
In the Main study, twenty experimental animals were epidermally treated on three occasions (Days 1, 8 and 15) with the undiluted test substance and ten control animals were similarly treated, but with vehicle alone (Kaydol white mineral oil). Two weeks after the last induction exposure, all animals were challenged with the undiluted test substance.
RESULTS: In the challenge phase, skin reactions of grade 1 were observed in seven experimental animals in response to the undiluted test substance. No skin reactions were evident in the control animals. Scaliness was seen in two of the experimental animals with grade 1 skin reactions.
CONCLUSION: The skin reactions observed in response to the undiluted test substance in seven of the twenty (35%) experimental animals in the challenge phase were considered indicative of sensitization, based on the ≥ 15% criteria for evidence of skin sensitisation and the absence of any response in the control animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
